Researchers have homed in on the group B coxsackie viruses….
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #14: Beta-Cell Replacement Therapy, Part 1 of 2
Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Andrew M. Posselt, MD, PhD, FACS, and Peter Stock, MD, PhD The goal of curing type 1 diabetes (T1D) is best achieved with beta-cell replacement therapy because this allows physiologic blood glucose control. Currently, the …
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #13: Setting Treatment Targets, Part 2 of 2
Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Jane Lee Chiang, MD, and Stephen E. Gitelman, MD GUIDELINES Current guidelines for glycemic control from select organizations worldwide are shown in Table 6.4.19-22,62 Due to the special nature of T1D, only those guidelines that …
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #12: Setting Treatment Targets, Part 1 of 2
Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Jane Lee Chiang, MD, and Stephen E. Gitelman, MD INTRODUCTION The Diabetes Control and Complications Trial (DCCT)1 was a landmark medical study conducted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). …
Read More »Social Deprivation, an Independent Risk Factor for Mortality in Type 1 Diabetes
Social deprivation, in addition to A1c and age, is tied to the increased risk of mortality in patients with type 1 diabetes….
Read More »Predictors of Type 1 Diabetes
Physical inactivity, preproinsulin, and inflammatory markers are predictors for type 1 diabetes….
Read More »